The aesthetic medicine market - Italy

This market study focuses mainly on the first segment. The value of the global aesthetic medicine market grows steadily from 2024 to 2032, from $21.5 billion to $53.2 billion with a compound annual crecsita rate of 12.0%. The overall increase is 147.4% over eight years, showing significant and progressive expansion. The market is led by the United States with 6.20 million surgeries through 2023. The Italian market is also growing, thanks in particular to the increasing popularity of so-called "non-invasive" methods of aesthetic medicine, placed on the borderline between medical treatment and simple aesthetic procedures. Italy is in fact the country in the world with the highest number of aesthetic medicine procedures in proportion to its population. In recent years, due to covid, this growth has come to a halt from which Italy is recovering more slowly than other countries. The Italian market is still predominantly driven by women, with 75.6 percent of procedures, but interest from men has grown in recent years. In fact, it is estimated that requests for non-surgical treatments by men have increased by 25.4 percent since 2008. Italians are resorting to aesthetic medicine from an increasingly younger age, as they prefer to prevent the signs of aging, instead of treating them, in the best possible way and with optimal results. In Italy, the injectables segment dominates the aesthetic medicine market, accounting for80.3 percent of all procedures. In fact, Hyaluronic acid fillers and botulinum toxin are the most popular nonsurgical procedures among Italians. The aesthetic medicine market requires high entry costs and advanced technology , and most manufacturers specialize in manufacturing. The market is constantly renewing, and in recent years there have been major technological advances that have enabled the spread of increasingly less invasive and more effective procedures, such as CoolSculpting and Rhinofiller .